Karlowsky J, Ferguson J, Zhanel G
Department of Medical Microbiology, Faculty of Medicine, University of Manitoba.
J Can Dent Assoc. 1993 Mar;59(3):292-4, 297-300.
The microflora associated with odontogenic infections are typically mixed and of indigenous origin. Streptococcus, peptostreptococcus, peptococcus, fusobacterium, bacteroides, and actinomyces species are the principle microflora isolated from these infections. Penicillin V (phenoxymethyl penicillin) remains the antimicrobial of choice for the initial empirical treatment of odontogenic infections. This agent is safe, highly effective and inexpensive. Amoxicillin has little indication for the routine treatment of odontogenic infections. However, it is the agent of choice for endocarditis prophylaxis, as it produces higher serum levels than penicillin V. Erythromycin may be used for mild, acute odontogenic infections in penicillin-allergic patients. The high incidence of gastrointestinal disturbances and superinfection commonly associated with the ingestion of tetracycline limits its role in general dental practice. Tetracycline may be considered as an alternative therapy for penicillin-allergic patients over the age of 13 who cannot tolerate erythromycin. Clindamycin is very effective against all odontogenic pathogens, but its potential gastrointestinal toxicity relegates it to third- or even fourth-line therapy in general dentistry. Although metronidazole displays excellent activity against anaerobic gram-negative bacilli, it is only moderately effective against facultative and anaerobic gram-positive cocci, and should not be used alone in the treatment of acute odontogenic infections.
与牙源性感染相关的微生物群落通常是混合性的且源自体内。链球菌、消化链球菌、消化球菌、梭杆菌、拟杆菌和放线菌属是从这些感染中分离出的主要微生物。青霉素V(苯氧甲基青霉素)仍然是牙源性感染初始经验性治疗的首选抗菌药物。该药物安全、高效且价格低廉。阿莫西林在牙源性感染的常规治疗中几乎没有应用指征。然而,它是预防心内膜炎的首选药物,因为它产生的血清水平高于青霉素V。红霉素可用于青霉素过敏患者的轻度急性牙源性感染。与服用四环素通常相关的胃肠道紊乱和二重感染的高发生率限制了其在一般牙科实践中的作用。对于13岁以上不能耐受红霉素的青霉素过敏患者,四环素可被视为一种替代疗法。克林霉素对所有牙源性病原体都非常有效,但其潜在的胃肠道毒性使其在一般牙科中沦为三线甚至四线治疗药物。尽管甲硝唑对厌氧革兰氏阴性杆菌显示出优异的活性,但它对兼性和厌氧革兰氏阳性球菌仅具有中等效力,且不应单独用于治疗急性牙源性感染。